Special Event 
Thursday, October 7th Panel Discussion
Anatomy of the Deal
Panelists: 
• Chris Cerimele, Director, Head of Chemicals Practice, Houlihan Lokey Bio Website (Chris will also serve as the Moderator)
• Randy Dearth, CEO, LANXESS Corp. Bio Website
• Jeff Kolke, Sr. Vice President, Corporate Finance, GE Capital Bio Website
• Bill Rowland, Partner, Jones Day Bio Website
• Drew Shea, Managing Partner, GenNx360 Capital Partners Bio Website
Sponsors: 
Houlihan Lokey Website
GenNx360 Capital Partners Website
Neil A. Burns, LLC Website
Host: Neil A. Burns, Managing Partner, Neil A. Burns, LLC
Reserve Early as this event will sell out. Reserve Now
Place: Club Quarters in Midtown New York City
40 West 45th Street (between Fifth & Sixth Avenues)
Times: • 11:00 a.m. - 2:00 p.m
• Networking: 11 a.m. - 12 noon • Lunch: 12 - 12:30 p.m.
• Presentation (webcast): 12:30 - 2:00 p.m.
Abstract: As predicted at the March CM&E Luncheon, the M&A market in chemicals is picking up. Recent evidence includes Bain Capital’s acquisition of Styron from Dow and the acquisition of Cognis by BASF, after 9 years of private equity ownership by Permira. Where are today’s opportunities and what are the key elements critical in making a transaction work?
Join friends and colleagues from the chemical, investment, legal and financial professions for a unique panel discussion on “the anatomy of a deal”. This special event is sponsored and moderated by Houlihan Lokey (the #1 rated M&A advisor for all US Industrial transactions by Thomson Reuters). Other sponsors to date include GenNx360 Capital Partners and Neil A Burns LLC.
The panel will examine current issues in M&A in the Chemical Industry from its own first-hand perspective. No airy trend-spotting from observers sitting in the stands! This session features only “players on the field” who will speak first-hand on what they experience daily in the world of Chemicals M&A. The five panelists are key players from each of the following areas: Investment Banking, Equity Investing, Lending, Legal and of course, the CEO. They will present, discuss and debate around some key questions, including:
a. What distinguishes a done deal from a failed deal?
b. How are the conflicting priorities of the parties resolved?
c. How to “change the rules” to achieve your deal goals and when to walk away.
This luncheon is part of the American Chemical Society’s CM&E Group's monthly luncheon series. The previous lunch with an M&A focus (in March featuring Tim Wilding of Oppenheimer) attracted a record attendance, so for this lunch we have moved to a larger room – still at the same Midtown Executive Club location (45th St. between 5th and 6th Avenues). As well as a stimulating program, we look forward to attendance by a great mix of chemicals executives, investors, lenders, lawyers and analysts. A number of business relationships were formed as the result of networking at our March event and we expect the same high quality interactions this time. Please book early as this event will sell out.
Fees: $55 for Members and $65 for Non-Members.
Save Now - Early-Bird rates: $45 for Members and $55 for Non-Members who pay via credit card by Monday, October 4th, 11 am. Reserve Now.
Webcast Option: $30 for Members and Non-Members. $10 discount, if you reserve by Monday, October 4th, 4 pm. This event will be available as a live Webcast (12:30 - 2:00 pm EDT on Thursday, October 7th). Reserve for webcast.
To Reserve for NY Luncheon: Please reserve early to be eligible for the discount price (only for pre-paid reservations). Reserve Now.
Archived Program - for Sep 2008 - June 2010 announcements
Previous Program since 2003-04 season